Dr. Mark Einstein, MD, MS

Claim this profile

University Hospital, Rutgers New Jersey Medical School

Studies Cervical dysplasia
Studies Atypical Squamous Cells
4 reported clinical trials
11 drugs studied

Area of expertise

1

Cervical Dysplasia

Mark Einstein, MD, MS has run 1 trial for Cervical dysplasia. Some of their research focus areas include:

HPV16
CIN2
2

Atypical Squamous Cells

Mark Einstein, MD, MS has run 1 trial for Atypical Squamous Cells. Some of their research focus areas include:

HPV16
CIN2

Affiliated Hospitals

Image of trial facility.

University Hospital, Rutgers New Jersey Medical School

Image of trial facility.

Rutgers New Jersey Medical School

Clinical Trials Mark Einstein, MD, MS is currently running

More about Mark Einstein, MD, MS

Clinical Trial Related

11 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Mark Einstein, MD, MS has experience with

  • Placebo
  • PNGVL4a-Sig/E7(detox)/HSP70 DNA
  • TA-CIN
  • Paclitaxel
  • VB-111
  • Fluorouracil

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Mark Einstein, MD, MS specialize in?

Is Mark Einstein, MD, MS currently recruiting for clinical trials?

Are there any treatments that Mark Einstein, MD, MS has studied deeply?

What is the best way to schedule an appointment with Mark Einstein, MD, MS?

What is the office address of Mark Einstein, MD, MS?

Is there any support for travel costs?